Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Why Shift Technologies Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket

Author: Lisa Levin | March 29, 2023 08:05am

Gainers

  • LogicMark, Inc. (NASDAQ:LGMK) shares rose 36.7% to $0.1914 in pre-market trading after the company reported strong revenue and margin growth for the year ended 2022.
  • Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) gained 36.3% to $0.6758 in pre-market trading. Biodexa Pharmaceuticals reported exercise of warrants and issue of equity.
  • Helbiz, Inc. (NASDAQ:HLBZ) gained 23.3% to $0.1419 in pre-market trading. Helbiz posted FY22 revenue of $15.5 million, up 21% year over year.
  • Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) climbed 22.5% to $19.00 in pre-market trading after the company reported upbeat fourth-quarter results and provided an update on pipeline progress.
  • Bird Global, Inc. (NASDAQ:BRDS) rose 18.1% to $0.2288 in pre-market after jumping 42% on Tuesday.
  • Cipher Mining Inc. (NASDAQ:CIFR) gained 14.7% to $2.18 in pre-market trading.
  • Lululemon Athletica Inc (NASDAQ:LULU) shares rose 14.4% to $366.53 in pre-market trading as the company reported better-than-expected Q4 results and issued strong forecast.
  • N-able, Inc. (NYSE:NABL) shares rose 13.6% to $13.80 in pre-market trading. N-able will replace iStar Incin the S&P SmallCap 600 on Monday, April 3.
  • Pyxis Oncology, Inc. (NASDAQ:PYXS) rose 9.9% to $4.23 in pre-market trading after jumping over 42% on Tuesday. Pyxis Oncology recently reported a loss of $3.65 per share in FY22.
  • Emergent BioSolutions Inc (NYSE:EBS) shares rose 7.8% to $9.59 in pre-market trading. Emergent BioSolutions, last month, posted a Q4 loss of $0.31 per share.

Losers

  • Draganfly Inc. (NASDAQ:DPRO) fell 17.5% to $1.18 in pre-market trading. Draganfly reported a proposed underwritten public offering to secure growth capital.
  • Shift Technologies, Inc (NASDAQ:SFT) shares dropped 14.8% to $1.43 in pre-market trading after reporting downbeat quarterly sales. Shift also announced regaining compliance with Nasdaq listing requirement.
  • SomaLogic, Inc. (NASDAQ:SLGC) fell 14.5% to $2.00 in pre-market trading after the company posted a wider-than-expected Q4 loss.
  • Minim, Inc. (NASDAQ:MINM) fell 11.9% to $0.1262 in pre-market ahead of quarterly earnings.
  • Sono Group N.V. (NASDAQ:SEV) fell 8.7% to $0.3150 in pre-market trading after declining around 7% on Tuesday. Sono Group recently received Nasdaq notification regarding minimum bid price deficiency.
  • Oriental Culture Holding LTD (NASDAQ:OCG) shares fell 6.7% to $0.41 in pre-market trading.
  • FOXO Technologies Inc. (NYSE:FOXO) fell 5.9% to $0.32 in pre-market trading. FOXO Technologies is expected to report financial results for the fourth quarter after the closing bell on Thursday, March 30, 2023.
  • Ault Alliance, Inc. (NYSE:AULT) shares fell 5.2% to $0.0920 in pre-market trading after gaining around 4% on Tuesday.
  • Unity Biotechnology, Inc. (NASDAQ:UBX) fell 4.6% to $1.67 in pre-market trading. Unity Biotechnology recently said its phase 2 ENVISION study did not meet its non-inferiority threshold due to strength in the control group.
  • IceCure Medical Ltd (NASDAQ:ICCM) fell 4.6% to $1.22 in pre-market trading after gaining 14% on Tuesday. IceCure Medical secured regulatory approval in China for commercial use of its IceSense3 Disposable Cryoprobes.

Now Read This: Check Out 3 High-Yielding Dividend Stocks In Industrials Sector From Wall Street's Most Accurate Analysts

Posted In: ARCT AULT BDRX BRDS CIFR DPRO EBS FOXO HLBZ ICCM LGMK LULU MINM NABL OCG PYXS SEV SFT SLGC UBX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist